Doctor profile · Federal record

Dr. Ryan Ragle, M.D.

Rheumatology Physician (CMS: Rheumatology) · Anchorage, AK

  • NPI 1073781951
  • Accepts Medicare
  • MIPS 65.5 / 100 · 2023
  • 20 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
3801 Lake Otis Pkwy Ste 300
Anchorage, AK 995085234
(907) 562-2277
fax (907) 563-3460
Additional location
3890 University Lake Dr Ste 110
Anchorage, AK 995084669

Credentials & registration

NPPES · NUCC
NPI registered
February 2008 — 18 yrs on file
Profile last updated
October 23, 2025
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Alaska #MED7510
Medicaid
AK #1579686

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1073781951. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
24,629
Distinct HCPCS
10
Medicare allowed
$533,716
HCPCS Description Services Patients Avg allowed
J3111 Injection, romosozumab-aqqg, 1 mg 13,860 25 $10
J1745 Injection, infliximab, excludes biosimilar, 10 mg 5,220 14 $33
J0897 Injection, denosumab, 1 mg 2,820 45 $24
99214 Established patient office or other outpatient visit, 30-39 minutes 581 303 $157
36415 Insertion of needle into vein for collection of blood sample 317 161 $8
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated 273 140 $4
86140 Measurement c-reactive protein for detection of infection or inflammation 270 141 $5
80053 Blood test, comprehensive group of blood chemicals 268 148 $10
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 264 145 $8
J3489 Injection, zoledronic acid, 1 mg 215 43 $8

In context: peer comparison

Among 4 peers in Anchorage Rheumatology Physician, average services per provider: 832. This provider delivers 30× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$788
Transactions
40
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 14 $174.09
Abbvie INC. 4 $92.83
Janssen Biotech, INC. 3 $88.20
Ucb, INC. 3 $58.10
Pfizer INC. 2 $53.55
Alexion Pharmaceuticals, INC. 2 $46.76
AstraZeneca Pharmaceuticals Lp 2 $46.40
Lilly USA, LLC 2 $42.83
Sobi, INC 2 $36.92
Novartis Pharmaceuticals Corporation 1 $28.85
GlaxoSmithKline, LLC. 1 $24.18
Genzyme Corporation 1 $23.34
Boehringer Ingelheim Pharmaceuticals, INC. 1 $21.36
Genentech USA, INC. 1 $19.01
Ani Pharmaceuticals, INC. 1 $16.49

By nature of payment

Food and Beverage
$769
Education
$19

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,798
Patients
357
Total drug cost
$1,300,540
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 450 102 $30,146
Methotrexate (Methotrexate Sodium) Brand 370 79 $14,322
Prednisone Generic 280 75 $2,625
Humira(Cf) Pen (Adalimumab) Brand 99 14 $1,008,042
Alendronate Sodium Generic 95 18 $1,019
Leflunomide Generic 88 20 $5,943
Celecoxib Generic 72 14 $1,641
Mycophenolate Mofetil Generic 58 11 $7,418
Leucovorin Calcium Generic 53 13 $458
Allopurinol Generic 50 11 $819

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Ryan Ragle's medical specialty?
Dr. Ryan Ragle practices Rheumatology Physician in Anchorage, AK.
Where does Dr. Ryan Ragle practice?
Dr. Ryan Ragle practices at 3801 Lake Otis Pkwy Ste 300, Anchorage, AK 995085234. Office phone: 9075622277.
What is Dr. Ryan Ragle's NPI?
Dr. Ryan Ragle's National Provider Identifier (NPI) is 1073781951, issued by NPPES.
Does Dr. Ryan Ragle accept Medicare assignment?
Yes. Dr. Ryan Ragle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ryan Ragle commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.